Pregnancy Testing Sample Clauses

Pregnancy Testing. Pregnancy testing will be performed only for female patients of childbearing potential as indicated in the SoA. A negative serum hCG pregnancy test must be obtained at Screening (≤ 3 days before selinexor administration). A urine hCG test is allowed if serum hCG test is not available. Pregnancy testing may be performed if clinically indicated during the study.
AutoNDA by SimpleDocs
Pregnancy Testing. WOCBP should only be included after a negative serum pregnancy test and in accordance with local requirements. When applicable this test should be repeated a maximum of 24- hours before the first dose of trial treatment. Following initiation of treatment additional pregnancy testing will be performed prior to day 1 of each cycle during the treatment period and at 30 days after the last dose of study treatment and as required locally. Pregnancy testing will be performed whenever an expected menstrual cycle is missed or when pregnancy is otherwise suspected.
Pregnancy Testing. For women with reproductive potential: serum or urine -HCG (urine test must have a sensitivity of 25-50 mIU/mL). After screening and entry, complete pregnancy testing only when pregnancy is suspected except as noted below.
Pregnancy Testing. Women of childbearing potential should only be included after a confirmed menstrual period and a negative highly sensitive urine pregnancy test at Screening, Baseline (Visit 3, prior to dosing), and at Week 12 or Early Withdrawal. A serum β-human chorionic gonadotropin test must be performed if the urine test is positive. Pregnancy testing will be performed whenever a menstrual cycle is missed or when pregnancy is otherwise suspected.
Pregnancy Testing. A urine pregnancy test will be conducted at Visit 1 and at Visits 6, 10 and 16 (48, 96 and 158 weeks from Visit 2) in all women of childbearing potential. Subjects with a positive pregnancy test should be withdrawn or excluded from entry to the study. If a subject becomes pregnant during the course of the study she must be withdrawn.
Pregnancy Testing. 7.5.8.1.2 Medical services during pregnancy and post-partum;
Pregnancy Testing. 7.5.8.3.5 A RhoGAM injection for all pregnant women who have a negative RH factor according to the established protocol;
AutoNDA by SimpleDocs
Pregnancy Testing. 7.5.8.4.3 Diagnosis and treatment of sexually transmitted diseases;
Pregnancy Testing. All WOCBP will have a SPT at the Screening and at Week 16/Early Termination visits and UPT at Injection visit pre-treatment. If any result is positive prior to treatment, the subject will not be allowed to participate. The results of the UPTs for WOCBP will be evaluated at the trial center. WOCBP must use an effective method of birth control during the course of the trial, such as the oral contraceptive pill, injection, implant, patch, vaginal ring, intrauterine coil, intrauterine device, tubal ligation, barrier method used WITH an additional form of contraception (e.g., sponge, spermicide or condom), abstinence, no heterosexual intercourse, or has a vasectomized partner. A female is considered to be of childbearing potential UNLESS she is post-menopausal (no menses for 12 consecutive months) or without a uterus and/or both ovaries. Before enrolling WOCBP in this clinical trial, Investigator must review guidelines about study participation for WOCBP. The topics should generally include: • Informed consent documentPregnancy prevention information • Risks to unborn child(ren) • Any drug interactions with hormonal contraceptives • Contraceptives in current useGuidelines for the follow-up of a reported pregnancy Prior to study enrollment, WOCBP must be advised of the importance of avoiding pregnancy during participation in this clinical trial and the potential risk factors for an unintentional pregnancy. The subject must sign the informed consent document stating that the above-mentioned risk factors and the consequences were discussed with her.

Related to Pregnancy Testing

  • Product Testing Upon request, Customer shall provide Operator a laboratory report for each Product delivery by Customer or Customer’s supplier. Operator will not be obligated to receive Contaminated Product for throughput through the Pipelines, nor will Operator be obligated to accept Product that fails to meet the applicable quality specifications for the Berths under the BAUTA and any Terminal Service Orders issued thereunder.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • Acceptance Testing At the time of installation of a LIS trunk group, and at no additional charge, acceptance tests will be performed to ensure that the service is operational and meets the applicable technical parameters.

  • Tests 7.7.1 If the Contract Documents, laws, ordinances, rules, regulations or orders of any public authority having jurisdiction require any portion of the Work to be inspected, tested or approved, the Contractor shall give the Architect timely notice of its readiness so the Architect may observe such inspection, testing or approval. The Contractor shall bear all costs of such inspections, tests or approvals conducted by public authorities.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!